Comparison of the effect of laser and medicine in glaucoma

Not Applicable

Recruiting

• Conditions: Primary open angle glaucoma.; Open-angle glaucoma; H40.1

• Registration Number: IRCT20230330057786N1
• Lead Sponsor: Zahedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age more than 18 years
Diagnosis of POAG (POAG is an optic neuropathy with increased intraocular pressure in which the angle of the anterior chamber of the eye is open and no secondary disease or cause can be found to justify optic nerve damage or increased intraocular pressure).
Newly diagnosed patients and those who are currently receiving the standard first-line treatment, i.e. latanoprost eye drops, but their target IOP has not been achieved.

Exclusion Criteria

Secondary glaucoma diagnosis
One eye patients (patients whose other eye is blind for any reason).
Having very high IOP (above 30 mm Hg)
Patients who have currently received the maximum tolerated medical treatment (Maximum Tolerated Medical Treatment), but despite the treatment, their IOP has not been controlled.
History of laser trabeculoplasty or retina surgery
History of cataract surgery in the last 3 months
Active eye infection or inflammation
Narrow eye angle
Pregnant or lactating women
Any eye disease that prevents accurate IOP measurement. Like a corneal scar
Any unstable medical condition that prevents compliance with the scientific and ethical bases of the study protocol.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of eye pressure reduction in glaucoma patients. Timepoint: At the beginning of the study (before the start of the intervention) and 1 month and 6 months after the start of the treatment. Method of measurement: Goldman tonometer.

Secondary Outcome Measures

Name	Time	Method
Visual acuity. Timepoint: At the beginning of the study (before the start of the intervention) and 1 month and 6 months after the start of the treatment. Method of measurement: Snellen vision measurement chart.